Sanbe Farma

Caprifarmindo Laboratories

  • Home
  • Our Profile
    • About Us
    • Vision & Mision
    • Facility
  • Product
    • Over The Counter (OTC)
      • Domestic Product
    • Prescription
      • Penicillin Antibiotic
      • Quinolone Antibiotic
      • Carbapenem Antibiotic
      • Cephalosporin Antibiotic
      • Chloramphenicol Antibiotic
    • Veterinary Vaccine Plant
      • Killed Virus Vaccine For Poultry
      • Live Virus Vaccine for Poultry
      • Inactivated Bacteria Vaccine for Poultry
      • Fish Vaccine
      • Tissue Culture Vaccine
      • Livestock Vaccine
    • Animal Health
  • Careers
  • Drug Complaint
  • Language : IND | ENG


    Quinolone Antibiotic





    produk

    CIPREC


    Box of 2 strips @ 10 caplets
    Reg. No. : DKL0632400909A1

    produk

    CIPREC


    Category
    Quinolone Antibiotic
    Type
    General Anaesthetic
    Package
    Box of 2 strips @ 10 caplets
    Reg. No. : DKL0632400909A1
    Composition
    Ciprofloxacin Hydrochloride equivalent to Ciprofloxacin 500 mg
    Indication
    CIPREC® is indicated for the treatment of infections caused by susceptible microorganisms to Ciprofloxacin :
    - Urinary tract infections, including prostatitis.
    - Urethritis and cervicitis gonorrhoeae.
    - Gastro-intestinal infections, including typhoid fever caused by Salmonella typhi. The efficacy of Ciprofloxacin in the eradication of the chronic thyphoid carrier state has not been demonstrated.
    Respiratory tract infections, except pneumonia caused by Streptococcus pneumoniae.
    - Skin and soft tissue infections.
    - Bone and joint infections.
    Dossage
    Adults :
    - Mild/moderate urinary tract infections : 250 mg twice daily.
    - Severe urinary tract infections : 500 mg twice daily.
    - Mild/moderate respiratory, bone, joint, skin, soft tissue infections : 250 to 500 mg twice daily.
    - Severe respiratory, bone, joint, skin, soft tissue infections : 500 to 750 mg twice daily.
    - Chronic prostatitis : 500 mg twice daily.
    - Gastrointestinal infections : 500 mg twice daily.
    - Acute gonorrhoea : a single dose of 250 mg.
    - To achieve the adequate dose in acute osteomyelitis, dose not less than 750 mg twice daily.

    Precaution
    - Effects on gastro-intestinal
    Nausea, vomiting, diarrhoea, gastro-intestinal disturbance, dyspepsia, abdominal pain, flatulence, anorexia, dysphagia. Consult to medical immediately if severe diarrhea occur or persistent during or after treatment, because this symptoms may cover the seriously disorders (pseudomembranous colitis) that need immediately action. If these occur, administration of Ciprofloxacin should be discontinued and change with other suitable drugs (ex. Vancomycin per oral, 250 mg tablet, 4 times daily). The inhibitor peristalsis drugs are contra-indicated to Ciprofloxacin.
    - Effects on central nervous system
    Dizziness, headache, weakness, insomia, agitation, tremor. Very rarely : peripheral paralgesia, sweating, seizure, anxiety, nightmares, confusion, depression, hallucinations, impaired taste and smell, disturbed vision (e.g. double vision, change in color perception. Those reactions occurred after taking Ciprofloxacin for the first time. In this case, Ciprofloxacin should be discontinued and consult to medical immediately.
    - Hypersensitivity reactions
    Skin reactions, e.g. rash, pruritus, drugs fever. Anaphylactic / anaphylactoid reactions (e.g. edema of the face, vascular and larynx, severe dyspnea to dangerous shock). In this case, treatment with Ciprofloxacin should be discontinued, medical emergency action (ex. shock treatment) should be done immediately.
    - Effects on renal/urogenital
    Interstitial nephritis, renal failure, transient renal failure, polyuria, urinary retention, urethral bleeding, vaginitis and acidosis.
    - Effects on hepatic
    Hepatitis, very rarely : liver disorders including hepatic necrosis.
    - Effects on cardiovascular system
    Rarely : tachycardia, palpitation, atrial flutter, ventricular ectopy, syncope, hypertension, angina pectoris, myocardial infarction, cardiopulmonary arrest, cerebral thrombosis, rash of face, migraine.
    - Other adverse reactions
    Rarely : joint pain, malaise, musculoskeletal pain, tendovaginitis, mild photosensitivity, tinnitus, impairment of hearing particularly at high frequencies, epistaxis, laryngeal or pulmonary edema, hemoptysis, dyspnea, bronchospasm, pulmonary embolism.
    - Effects on hematologics
    Eosinophilia, leucopenia, leucocytosis, anemia, granulocytopenia.
    Very rarely : thrombocytopenia, thrombocytosis, altered prothrombin levels.
    - Effect on laboratory results / urine deposit
    Plasma levels of transaminase and alkaly phosphatase may increase temporary; cholestic icterus may occur particularly in patients who disorder experienced; increase of urea, creatinine & bilirubin levels transiently; hyperglycemia; in certain case : crystalluria and hematuria.
    Download Catalogue
    Download

    produk

    FLOXACAP


    FLOXACAP® Film-Coated Tablet
    Box of 3 strips @ 6 tablets.
    Reg. No.: DKL0932403317A1

    FLOXACAP® Infusion
    Softbag with net contents ...

    produk

    FLOXACAP


    Category
    Quinolone Antibiotic
    Type
    Quinolones
    Package
    FLOXACAP® Film-Coated Tablet
    Box of 3 strips @ 6 tablets.
    Reg. No.: DKL0932403317A1

    FLOXACAP® Infusion
    Softbag with net contents 100 mL.
    Reg. No.: DKL1032405449A1
    Composition
    FLOXACAP® Film-Coated Tablet
    Each film-coated tablet contains :
    Levofloxacin Hemihydrate equivalent to 500 mg of Levofloxacin.

    FLOXACAP® Infusion
    Each 100 mL solution contains:
    Levofloxacin Hemihydrate equivalent to Anhydrous Levofloxacin 50 mg
    Water for injection ad 100 mL
    Osmolarity: 290 mOsm/L
    Indication
    Treatment for patients = 18 years of age of the following infections due to Levofloxacin susceptible microorganisms:
    - Acute maxillary sinusitis.
    - Acute exacerbation of chronic bronchitis.
    - Community-acquired pneumonia.
    - Complicated urinary tract infection including mild to moderate pyelonephritis.
    - Uncomplicated skin and skin structure infections (mild to moderate).
    - Levofloxacin i.v. is only given to the patients who are unable to tolerate the oral dosage form.
    Dossage
    Dosage :
    Oral
    Common dose are 250 - 500 mg once daily (every 24 hour) in patients with normal renal functions (creatinine clearance > 80 mL/minute). Duration of administration between 7 - 14 days (depends on the level of infection).
    Precaution
    - If hypersensitivity reactions (skin rash, hives or other skin reactions, a rapid heartbeat, difficulty in swallowing or breathing, swelling of the lips, tongue, face, tightness of the throat, hoarseness) or other symptoms of allergy occur, the drug should be discontinued.
    - Should be used with caution in patients with renal insufficiency (creatinine clearance < 50 mL/minute), adjustment of the dosage regimen is necessary to avoid the accumulation of Levofloxacin.
    - Observe caution while operating an automobile or machinery or performing other tasks requiring coordination.
    - Discontinue treatment and inform their physician if they experience pain, inflammation, or rupture of a tendon.
    - Avoid excessive sunlight while receiving Levofloxacin and discontinue therapy if phototoxicity occurs.
    - Diabetic patients which being treated with insulin or an oral antidiabetic agent and hypoglycemic reaction occurs, they should discontinue Levofloxacin and consult a physician.
    - Should be used with caution in any patient with a known or suspected central nervous system disorder that may predispose to seizures or lower the seizure threshold (e.g. severe cerebral arteriosclerosis, epilepsy) or in the presence of other risk factors that may predispose to seizures or lower the seizures threshold.
    - Convulsion and toxic psychoses have been reported in patients receiving quinolones (including Levofloxacin). Quinolones may also cause increase intracranial pressure and central nervous system stimulation which may lead to restlessness, lightheadedness, tremors, hallucinations, depression, paranoia and nightmares. If these reactions occur, the drug should be discontinued.
    - Serious and fatal hypersensitivity reactions often occur following the first dose. Some reactions have been accompanied by urticaria, itching and other serious skin reactions, dyspnea, respiratory obstruction, angioedema, hypotension, shock and cardiovascular collapse. The drug should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity.
    - Treatment with antibacterial agents (including Levofloxacin) alters the normal flora of the colon and may cause overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of colitis.
    - Pseudomembranous colitis has been reported with nearly all antibacterial agents (including Levofloxacin), and may range in severity from mild to life threatening. Therefore, it is importantto consider this diagnosis in patients who present with diarrhea subsequent to the administration of any other antibacterial agent.
    Download Catalogue
    Download




    Contact Center

    022-4207725
    Email : -
    Website : www.caprifarmindo.com
    PT. Caprifarmindo Purnawarman Street No. 47, Bandung


    © 2023 PT. Caprifarmindo